FDA
publication date
Payer
Why Do Americans Pay More for Prescription Drugs?
Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize...
Payer
RFK Jr. Struggles to Navigate Frustrated Supporters and a Demanding Boss
Kennedy's allies say he's become almost inaccessible since his confirmation and has made glacial progress advancing MAHA goals.
Innovation
A Path for AI ROI? Lawmakers Float Bill for Medicare Reimbursement
Two U.S. Senators have co-sponsored a bill that would create a better pathway for Medicare coverage of FDA-approved AI tools...
Pharma
Marty Makary, Often Wrong as Pandemic Critic, Is Poised to Lead the FDA He Railed Against
Critics say he exaggerated the harms of the COVID vaccine and undersold the dangers of the virus.
CEO
Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment
A cadre of health business leaders and nonmainstream doctors are influencing Trump's focus on health policy.
CEO
Trump's White House Return: Healthcare Safety Net Implications
Trump's victory will give a far broader platform to skeptics and critics of federal health programs and actions.
HLM Mastermind
FDA to Ramp Up Surveillance of Potentially Faulty Medical Devices
More than 1.7 million patient injuries and 83,000 deaths have been linked to defective medical equipment over a 10-year span.
HLM Mastermind
The FDA Calls Them 'Recalls,' Yet the Targeted Medical Devices Often Remain in Use
From 2019 through 2023, there were 338 Class I medical device recalls, 164 of which were corrections and 174 of...
Innovation
An AI Cure for the Stuffy Nose?
The latest in digital therapeutics features a new device that uses Ai to scan a patient?s sinuses and create an...
Pharma
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
The heavier dosage allows AmGen to protect 75% of its revenue from the drug, which earned $200 million last year.
Pharma
Opioid Maker Endo Health Solutions to Pay $1.1B, Forfeit $450M
It's the second-largest criminal financial penalty levied against a drug maker.
Payer
FDA Finally Moves to Scrutinize Specialized Health Screenings
The agency issued a rule that brings new scrutiny to a range of critical lab-developed tests, including certain cancer and...